Retrospective analysis between PD-L1 expression and prognosis for stage III non-small cell lung cancer patients

被引：0
|
作者：
Tokito, Takaaki [1 ]
Azuma, Koichi [1 ]
Ishii, Hidenobu [1 ]
Yamada, Kazuhiko [1 ]
Hoshino, Tomoaki [1 ]
机构：
[1] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O3-1-3
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [1] Retrospective analysis between PD-L1 expression and prognosis for stage III non-small cell lung cancer patients who received concurrent chemoradiotherapy.
    Tokito, Takaaki
    Azuma, Koichi
    Ishii, Hidenobu
    Yamada, Kazuhiko
    Hoshino, Tomoaki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] PD-L1 expression and survival in stage III unresectable non-small cell lung cancer patients in Denmark
    Cronin-Fenton, D.
    Dalvi, T.
    Movva, N.
    Pedersen, L.
    Hansen, H.
    Fryzek, J.
    Mellemgaard, A.
    Rasmussen, T.
    Klein, A. B.
    Hamilton-Dutoit, S.
    Norgaard, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S808 - S808
  • [3] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
  • [4] PD-L1 expression in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy.
    Mamesaya, Nobuaki
    Kenmotsu, Hirotsugu
    Miyawaki, Eriko
    Kotake, Mie
    Kawamura, Takahisa
    Kobayashi, Haruki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy
    Vrankar, Martina
    Kern, Izidor
    Stanic, Karmen
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [6] Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy
    Martina Vrankar
    Izidor Kern
    Karmen Stanic
    Radiation Oncology, 15
  • [7] Prognostic Significance of PD-L1 in Stage II/III Non-Small Cell Lung Cancer
    Karaca, M.
    Tura, D.
    Ozet, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S628 - S628
  • [8] PD-L1 expression, EGFR and KRAS mutations in unresectable stage III non-small cell lung cancer (NSCLC) patients
    Cronin-Fenton, Deirdre
    Dalvi, Tapashi
    Hedgeman, Elizabeth
    Norgaard, Mette
    Pedersen, Lars
    Hansen, Hanh
    Fryzek, Jon
    Walker, Jill
    Mellemgaard, Anders
    Rasmussen, Torben
    Shire, Norah
    Riggas, James
    Potter, Danielle
    Hamilton-Dutoit, Stephen
    Sorensen, Henrik
    CANCER RESEARCH, 2018, 78 (13)
  • [9] Quantification of PD-L1 expression in non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S402 - S404
  • [10] PD-L1 expression testing in non-small cell lung cancer
    Teixido, Cristina
    Vilarino, Noelia
    Reyes, Roxana
    Reguart, Noemi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
12345